These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28007341)

  • 1. Better late than never: PrEP in England.
    The Lancet Hiv
    Lancet HIV; 2017 Jan; 4(1):e1. PubMed ID: 28007341
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
    Cambiano V; Miners A; Dunn D; McCormack S; Ong KJ; Gill ON; Nardone A; Desai M; Field N; Hart G; Delpech V; Cairns G; Rodger A; Phillips AN
    Lancet Infect Dis; 2018 Jan; 18(1):85-94. PubMed ID: 29054789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States.
    Leech AA; Burgess JF; Sullivan M; Kuohung W; Horný M; Drainoni ML; Christiansen CL; Linas BP
    AIDS; 2018 Nov; 32(18):2787-2798. PubMed ID: 30234602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Welcome to the preexposure prophylaxis revolution.
    Baeten J; McCormack S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):1-2. PubMed ID: 26633637
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    Parikh UM; Mellors JW
    Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK PrEP decision re-ignites HIV activism.
    The Lancet
    Lancet; 2016 Apr; 387(10027):1484. PubMed ID: 27115959
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on HIV prevention and preexposure prophylaxis.
    Baker J; Rolls J
    JAAPA; 2020 Jun; 33(6):12-17. PubMed ID: 32384293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
    Ebell MH
    Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
    [No Abstract]   [Full Text] [Related]  

  • 10. Is sub-Saharan Africa ready for pre-exposure prophylaxis?
    Bernier A; Gapiya J; Sylla A; Anoma C; Somda M; Dah E; Aranda JF; Himmich H
    Lancet HIV; 2016 Apr; 3(4):e154-5. PubMed ID: 27036989
    [No Abstract]   [Full Text] [Related]  

  • 11. In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
    Mitchell KM; Dimitrov D; Hughes JP; Xia F; Donnell D; Amico KR; Bokoch K; Chitwarakorn A; Bekker LG; Holtz TH; Mannheimer S; Grant RM; Boily MC
    AIDS; 2018 Mar; 32(6):809-818. PubMed ID: 29424774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to "PrEP" for HIV Prevention in Women.
    Ntim GJ; Kransdorf LN
    J Womens Health (Larchmt); 2017 Feb; 26(2):195-196. PubMed ID: 28140756
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-exposure prophylaxis is effective at preventing HIV in high risk gay men, study shows.
    Mayor S
    BMJ; 2015 Sep; 351():h4860. PubMed ID: 26359448
    [No Abstract]   [Full Text] [Related]  

  • 14. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of tenofovir disoproxil fumarate and emtricitabine in generic pre-exposure prophylaxis tablets obtained from the internet.
    Wang X; Nutland W; Brady M; Green I; Boffito M; McClure M
    Int J STD AIDS; 2019 Jul; 30(8):765-768. PubMed ID: 31072205
    [No Abstract]   [Full Text] [Related]  

  • 16. Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective.
    Conniff J; Evensen A
    J Am Board Fam Med; 2016; 29(1):143-51. PubMed ID: 26769887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrEP: why are we waiting?
    Lancet HIV
    Lancet HIV; 2015 Oct; 2(10):e401. PubMed ID: 26423641
    [No Abstract]   [Full Text] [Related]  

  • 18. New PrEP formulation approved…but only for some.
    The Lancet Hiv
    Lancet HIV; 2019 Nov; 6(11):e723. PubMed ID: 31672278
    [No Abstract]   [Full Text] [Related]  

  • 19. For the greatest impact, end caps on PrEP access now.
    The Lancet Hiv
    Lancet HIV; 2019 Feb; 6(2):e67. PubMed ID: 30686720
    [No Abstract]   [Full Text] [Related]  

  • 20. Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
    Durand-Zaleski I; Mutuon P; Charreau I; Tremblay C; Rojas D; Pialoux G; Chidiac C; Capitant C; Spire B; Cotte L; Chas J; Meyer L; Molina JM;
    AIDS; 2018 Jan; 32(1):95-102. PubMed ID: 29210777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.